Macro Biologics creates synthetic biological polymers for therapeutic and biotechnology applications.
Macro Biologics has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Macro Biologics's investors include CARB-X.
Macro Biologics is headquartered in Carlsbad, United States.
Macro Biologics creates synthetic biological polymers for therapeutic and biotechnology applications.
Macro Biologics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Macro Biologics — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/macro-biologics. Accessed September 30, 2026.
VCBacked. (2025). Macro Biologics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/macro-biologics
{{cite web |title=Macro Biologics — Funding & Investors |url=https://www.vcbacked.co/company/macro-biologics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated